See more : Technology Metals Australia Limited (TMT.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Mercury Laboratories Limited (MERCURYLAB.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Mercury Laboratories Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- GrowLife, Inc. (PHOT) Income Statement Analysis – Financial Results
- Site Group International Limited (SIT.AX) Income Statement Analysis – Financial Results
- Aviva plc (AIVAF) Income Statement Analysis – Financial Results
- Canamera Energy Metals Corp. (EMET.CN) Income Statement Analysis – Financial Results
- ENN Energy Holdings Limited (XNGSF) Income Statement Analysis – Financial Results
Mercury Laboratories Limited (MERCURYLAB.BO)
About Mercury Laboratories Limited
Mercury Laboratories Ltd. engages in the production and sale of pharmaceuticals and its related products. It offers products for pediatrics, obstetrics, gynecology, surgery, and general sectors. The company was founded in 1962 and is headquartered in Vadodara, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 755.59M | 753.34M | 579.24M | 686.01M | 572.69M | 555.04M | 518.68M | 480.27M | 475.17M |
| Cost of Revenue | 305.39M | 304.16M | 236.60M | 457.50M | 399.21M | 390.63M | 353.66M | 308.49M | 302.22M |
| Gross Profit | 450.20M | 449.18M | 342.64M | 228.52M | 173.48M | 164.42M | 165.01M | 171.78M | 172.95M |
| Gross Profit Ratio | 59.58% | 59.62% | 59.15% | 33.31% | 30.29% | 29.62% | 31.81% | 35.77% | 36.40% |
| Research & Development | 245.00K | 85.00K | 241.00K | 25.82K | 415.74K | 160.44K | 656.58K | 465.85K | 0.00 |
| General & Administrative | 16.03M | 0.00 | 8.92M | 11.21M | 10.15M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 45.20M | 0.00 | 28.07M | 37.62M | 37.21M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 61.22M | 163.24M | 36.99M | 130.05M | 112.44M | 115.47M | 122.17M | 105.46M | 105.91M |
| Other Expenses | 388.73M | 17.19M | 8.16M | -15.43M | -16.16M | -6.58M | -11.52M | -7.88M | -12.82M |
| Operating Expenses | 450.20M | 388.31M | 297.27M | 145.51M | 129.02M | 122.22M | 134.35M | 113.80M | 118.73M |
| Cost & Expenses | 692.06M | 692.47M | 533.87M | 603.00M | 528.23M | 512.85M | 488.01M | 422.29M | 420.96M |
| Interest Income | 1.20M | 1.24M | 884.00K | 574.66K | 688.18K | 689.01K | 820.02K | 672.67K | 636.13K |
| Interest Expense | 3.83M | 3.62M | 4.46M | 6.41M | 8.17M | 10.88M | 9.07M | 8.92M | 9.79M |
| Depreciation & Amortization | 28.16M | 24.83M | 24.53M | 19.21M | 18.69M | 16.28M | 14.74M | 12.89M | 11.84M |
| EBITDA | 101.19M | 102.90M | 79.34M | 104.71M | 70.15M | 67.66M | 48.37M | 70.75M | 70.98M |
| EBITDA Ratio | 13.39% | 13.66% | 13.48% | 14.90% | 11.03% | 10.54% | 8.76% | 14.76% | 13.90% |
| Operating Income | 62.15M | 62.62M | 48.62M | 83.01M | 44.46M | 42.20M | 30.67M | 57.98M | 54.22M |
| Operating Income Ratio | 8.23% | 8.31% | 8.39% | 12.10% | 7.76% | 7.60% | 5.91% | 12.07% | 11.41% |
| Total Other Income/Expenses | 7.06M | 12.31M | 1.72M | -3.92M | -1.33M | -442.31K | -6.11M | -9.04M | -4.86M |
| Income Before Tax | 69.20M | 74.93M | 50.34M | 79.09M | 43.29M | 40.51M | 24.56M | 48.94M | 49.36M |
| Income Before Tax Ratio | 9.16% | 9.95% | 8.69% | 11.53% | 7.56% | 7.30% | 4.73% | 10.19% | 10.39% |
| Income Tax Expense | 12.66M | 19.14M | 14.73M | 25.71M | 11.01M | 12.14M | 4.43M | 21.91M | 10.13M |
| Net Income | 56.54M | 55.79M | 35.62M | 53.38M | 32.28M | 28.36M | 20.13M | 27.03M | 39.23M |
| Net Income Ratio | 7.48% | 7.41% | 6.15% | 7.78% | 5.64% | 5.11% | 3.88% | 5.63% | 8.26% |
| EPS | 47.12 | 46.49 | 29.68 | 44.48 | 26.90 | 23.63 | 16.78 | 22.53 | 32.69 |
| EPS Diluted | 47.12 | 46.49 | 29.68 | 44.48 | 26.90 | 23.63 | 16.78 | 22.53 | 32.69 |
| Weighted Avg Shares Out | 1.20M | 1.20M | 1.20M | 1.20M | 1.20M | 1.20M | 1.20M | 1.20M | 1.20M |
| Weighted Avg Shares Out (Dil) | 1.20M | 1.20M | 1.20M | 1.20M | 1.20M | 1.20M | 1.20M | 1.20M | 1.20M |
Source: https://incomestatements.info
Category: Stock Reports